Clinical Trials in CNS
Venue: Marriott Regents Park
|Event Date/Time: Nov 23, 2011||End Date/Time: Nov 24, 2011|
Clinical Trials in CNS
23rd & 24th November 2011, Marriott Hotel Regentâ€™s Park, Central London, UK
SMi is delighted to announce its 10th annual Clinical Trials in CNS conference, bringing together leading industry experts to explore the current and future opportunities within CNS drug development.
This conference aims to cover clinical drug discovery activities, new therapeutic targets, as well as effective CNS drug development strategies and problems encountered in clinical trials, with in-depth discussions and case study presentations from the key industry players.
Focusing on a wide range of therapeutic areas such Multiple Sclerosis, Parkinsonâ€™s and Alzheimerâ€™s, as well as analysing psychiatric disorders schizophrenia and depression, this event will be a valuable opportunity to discuss with industry leaders the current landscape in clinical CNS drug development, as well as leaning about some of the most cutting edge translational research.
Our confirmed speakers include:
â€¢ Georg Terstappen, Director and Department Head, Neuroscience Discovery, Abbott
â€¢ Florien von Raison , Head of ,Global Clinical Development Unit Parkinsonâ€™s Disease, Merck Serono
â€¢ Peter Joseph Jongen, Founding Director, MS4 Research Institute
â€¢ Sophie Dix, Senior Research Scientist, Neurodegenerative Diseases Drug Hunting Team, Lilly
â€¢ Ge Ruigt, Director Experimental Medicine Neuroscience, Merck
â€¢ Paul Thompson, Associate, Director Discovery Medicine Unit, GSK
â€¢ Hitendra Parmar, European Medical Director for Alzheimerâ€™s Disease, Pfizer
â€¢ Chas Bountra, Chief Scientist, Structural Genomics Consortium, University of Oxford
â€¢ David Dexter, Reader in NeuroPharmacology Department of Medicine, Imperial College London
PLUS: AN INTERACTIVE HALF-DAY PRE-CONFERENCE WORKSHOP
Innovation, superiority and best practice proof-of-concept in CNS clinical development
22th November 2011 Marriott Regentâ€™s Park, London
Erik Buntinx, CEO â€“ Managing Director, PharmaNeuroBoost
Visit http://www.smi-online.co.uk/2011cnstrials11.asp to register!
Sponsorship and Exhibition Opportunities are available
To find out more, contact Alia Malick - Head of Pharmaceuticals
On tel: +44 (0)20 7827 6168 or email: email@example.com
Alternatively contact Mohammed Saffaf on Tel: +44 (0) 20 7827 6022 or email: firstname.lastname@example.org